| Not Yet Recruiting | The Correlation Between hs CRP TG Triglycerides Glucose Index in NAFLD and Liver Fibrosis NCT07513922 | Assiut University | — |
| Not Yet Recruiting | Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD) NCT07530419 | Seoul National University Hospital | — |
| Not Yet Recruiting | Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabet NCT07475962 | Institut de Recherches Cliniques de Montreal | — |
| Not Yet Recruiting | Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls NCT07394309 | Beijing Continent Pharmaceutical Co, Ltd. | Phase 1 |
| Not Yet Recruiting | A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in NCT07412236 | Beijing Continent Pharmaceutical Co, Ltd. | Phase 3 |
| Recruiting | City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Proj NCT07031089 | University Hospital, Grenoble | — |
| Not Yet Recruiting | The Phase Ⅰd Clinical Trial of Hydronidone Capsules NCT07262346 | Beijing Continent Pharmaceutical Co, Ltd. | Phase 1 |
| Not Yet Recruiting | Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients NCT07168551 | Assiut University | — |
| Not Yet Recruiting | Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France NCT07038863 | Hospices Civils de Lyon | N/A |
| Recruiting | Incidence of Liver Disease-Related Outcomes in People With HIV NCT06940375 | Shanghai Public Health Clinical Center | — |
| Recruiting | Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821 | Pichamol Jirapinyo, MD, MPH | N/A |
| Not Yet Recruiting | Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia NCT07011199 | Universitas Diponegoro | Phase 1 |
| Recruiting | Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis NCT07271576 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Recruiting | The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver NCT07069725 | AstraZeneca | Phase 1 |
| Recruiting | Evaluation of Non-Invasive Tests for Metabolic Liver Disease NCT07122700 | Foundation for the National Institutes of Health | — |
| Enrolling By Invitation | Effect of Mediterranean Diet Combined With Intermittent Fasting on Liver Fibrosis Compared to Naltrexone/Bupro NCT06845345 | Carmen Dietvorst | Phase 4 |
| Not Yet Recruiting | Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments NCT06918886 | Bezmialem Vakif University | — |
| Not Yet Recruiting | Assessment of Methotreaxate-induced Liver Fibrosis by Transient Elastography and Serological Markers NCT06872073 | Assiut University | — |
| Enrolling By Invitation | Endosonographic Shear Wave Elastography to Assess Liver and Splenic Fibrosis NCT06867731 | Providence Medical Research Center | — |
| Recruiting | MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B NCT06779058 | Shengjing Hospital | — |
| Completed | A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosi NCT06750276 | AstraZeneca | Phase 2 |
| Recruiting | Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Stor NCT07303140 | University Hospital, Strasbourg, France | — |
| Recruiting | LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Mod NCT06632444 | Boehringer Ingelheim | Phase 3 |
| Completed | Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- Tha NCT07153926 | Tanta University | — |
| Recruiting | Prediction of Significant Liver Fibrosis NCT06509230 | Huang Haijun | — |
| Recruiting | Fibrosis Lessens After Metabolic Surgery NCT06374875 | Ali Aminian | Phase 4 |
| Not Yet Recruiting | Precise Evaluation Criteria for Histological Regression of NASH Fibrosis NCT06364462 | Beijing Friendship Hospital | — |
| Unknown | Early Liver Disease Breath Detection NCT05935488 | Owlstone Ltd | — |
| Recruiting | Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127 | Beijing Friendship Hospital | — |
| Unknown | Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD NCT06147947 | Fifth Affiliated Hospital, Sun Yat-Sen University | — |
| Unknown | Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD NCT06147934 | Fifth Affiliated Hospital, Sun Yat-Sen University | — |
| Unknown | Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLD NCT06144437 | Fifth Affiliated Hospital, Sun Yat-Sen University | — |
| Unknown | Multispectral Optoacoustic Tomography in Patients With Cystic Fibrosis NCT06063785 | University of Erlangen-Nürnberg Medical School | — |
| Unknown | Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in NCT06051669 | New Discovery LLC | — |
| Recruiting | Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis NCT05905172 | Beijing Continent Pharmaceutical Co, Ltd. | Phase 3 |
| Recruiting | Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study NCT05974904 | Chongqing Medical University | — |
| Completed | Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease NCT05506488 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1 / Phase 2 |
| Unknown | Multiomics Study of Fibrosis Factors After Liver Transplantation and Exploration of Fibrosis Methylation Bioma NCT05926778 | RenJi Hospital | — |
| Recruiting | Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans NCT05526144 | VA Office of Research and Development | Phase 2 |
| Withdrawn | Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry NCT05817994 | Sheikh Shakhbout Medical City | — |
| Recruiting | Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients NCT05699018 | University Hospital, Angers | N/A |
| Completed | Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Un NCT05602870 | University Hospital, Montpellier | N/A |
| Recruiting | Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease NCT07265544 | Nanfang Hospital, Southern Medical University | — |
| Recruiting | Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFL NCT05644717 | Getz Pharma | Phase 4 |
| Unknown | Prospective Single Centre Observational Study to Compare the Diagnostic Yield of Different Modalities of Liver NCT05912179 | Nottingham University Hospitals NHS Trust | — |
| Unknown | Screening of Liver Fibrosis in Adults Without Known Liver Disease NCT05486767 | F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica | — |
| Unknown | Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests NCT05457543 | Group K Diagnostics Inc. | — |
| Recruiting | Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel NCT05308628 | RenJi Hospital | N/A |
| Completed | Different Doses of ZED1227 vs. Placebo in NAFLD NCT05305599 | Dr. Falk Pharma GmbH | Phase 2 |
| Completed | The Visceral Adiposity Measurement and Observation Study NCT05383456 | Theratechnologies | — |
| Recruiting | Efficacy of Simvastatin in Alcoholic Liver Fibrosis NCT04971577 | Anna Cruceta | Phase 2 / Phase 3 |
| Unknown | Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR. NCT05239260 | Medical University of Vienna | — |
| Completed | Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch NCT05224037 | Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology | N/A |
| Recruiting | Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics NCT05490888 | PharmaIN | Phase 1 |
| Completed | Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial. NCT05115942 | Beijing Continent Pharmaceutical Co, Ltd. | Phase 3 |
| Unknown | 18F-FAPI PET in the Diagnosis of Liver Fibrosis NCT05262647 | The Affiliated Hospital of Qingdao University | — |
| Completed | Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 NCT05180162 | Thomas Hope | Phase 1 |
| Recruiting | Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With NCT06308757 | University of Bologna | N/A |
| Completed | Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic NCT06244550 | Taipei City Hospital | N/A |
| Completed | Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation NCT05168982 | Chinese University of Hong Kong | — |
| Completed | Study in Healthy Adults Evaluating PF-07202954 NCT04857437 | Pfizer | Phase 1 |
| Unknown | Bariatric Endoscopy and NAFLD NCT04895943 | University Hospital Ostrava | — |
| Completed | Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Ex NCT04747457 | Echosens | N/A |
| Unknown | Effect of Imatinib in Advance Liver Fibrosis Patients NCT05224128 | Research Institute for Gastroenterology and Liver Diseases (RIGLD) | Phase 1 / Phase 2 |
| Unknown | HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and NCT04640129 | Third Affiliated Hospital, Sun Yat-Sen University | Phase 4 |
| Unknown | Bariatric Endoscopy and NAFLD NCT04669470 | University of Ostrava | N/A |
| Completed | The Role of Immune Semaphorins in NAFLD NCT04573543 | University Hospital for Infectious Diseases, Croatia | — |
| Unknown | 68Ga-FAPI PET/CT in Liver Fibrosis Patients NCT04533828 | First Affiliated Hospital of Fujian Medical University | EARLY_Phase 1 |
| Completed | Serum Regucalcin Level and Chronic Hepatitis B NCT05435599 | Konya Meram State Hospital | N/A |
| Unknown | Clinical Application of Fibroblast Activation Protein PET/MRI in Liver Fibrosis NCT04605939 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | N/A |
| Recruiting | Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver Fibrosis NCT04429100 | Chinese University of Hong Kong | — |
| Withdrawn | Three-Dimensional T1rho Using Spiral Fast Spin Echo NCT05154656 | Chinese University of Hong Kong | — |
| Withdrawn | A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients NCT02289300 | A2 Healthcare Taiwan Corporation | Phase 2 |
| Completed | Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study) NCT04146636 | University Hospital, Angers | N/A |
| Unknown | Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis NCT03957629 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Completed | Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients NCT03872024 | Echosens | N/A |
| Completed | T1rho Imaging of Liver in Presence of Iron NCT05154643 | Chinese University of Hong Kong | — |
| Completed | Pirfenidone and Advanced Liver Fibrosis. NCT04099407 | Grupo Mexicano para el Estudios de las Enfermedades Hepaticas | Phase 2 |
| Unknown | MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool NCT04168619 | The University of Hong Kong | — |
| Terminated | Liver and the Spleen Stifness in Adult Patients With Gaucher's Disease Using Ultrasound Shear Wave Elastograph NCT03896607 | HaEmek Medical Center, Israel | — |
| Active Not Recruiting | Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota NCT03863730 | Odense University Hospital | N/A |
| Unknown | Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibro NCT03920605 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver NCT03919565 | Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Completed | The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis NCT03957070 | Sonic Incytes | N/A |
| Completed | NAFLD and Liver Fibrosis in Obese Adolescents NCT04561804 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Early Detection of Advanced Fatty Liver Disease NCT03608748 | HaEmek Medical Center, Israel | — |
| Unknown | Functional MRI to Determine Severity of Cirrhosis NCT03623360 | University of Leeds | — |
| Completed | Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral NCT03908294 | Johann Wolfgang Goethe University Hospital | — |
| Completed | A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 L NCT03486899 | Bristol-Myers Squibb | Phase 2 |
| Completed | A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cir NCT03486912 | Bristol-Myers Squibb | Phase 2 |
| Terminated | Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in NCT03539757 | Children's Hospital Medical Center, Cincinnati | — |
| Terminated | Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan NCT03479125 | Conatus Pharmaceuticals Inc. | — |
| Completed | A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis NCT03420768 | Bristol-Myers Squibb | Phase 2 |
| Completed | A Study of Experimental Medication BMS-986036 Given to Healthy Participants NCT03445208 | Bristol-Myers Squibb | Phase 1 |
| Unknown | A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers NCT03568578 | Peking University First Hospital | N/A |
| Completed | ObeSity Related Colorectal Adenoma Risk NCT03663062 | South Tyneside and Sunderland NHS Foundation Trust | — |
| Unknown | Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension NCT03277651 | Shanghai Zhongshan Hospital | — |
| Unknown | Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation NCT04908657 | National Taiwan University Hospital | Phase 4 |
| Completed | Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography NCT03342560 | Massachusetts General Hospital | N/A |
| Unknown | Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI NCT03176797 | Zhujiang Hospital | N/A |
| Unknown | Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01) NCT03293953 | Ente Ospedaliero Ospedali Galliera | — |
| Unknown | Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI NCT03173287 | University Hospital, Clermont-Ferrand | N/A |
| Completed | Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging NCT03637959 | Mayo Clinic | N/A |
| Unknown | Mechanism of Serum PRL in the Development of MAFLD NCT05525884 | Shen Qu | — |
| Completed | A Nomogram for Evaluating Significant Liver Fibrosis in Patients With Chronic Hepatitis B Virus Infection NCT05560503 | Xiangya Hospital of Central South University | — |
| Completed | FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) NCT02922751 | Arbor Research Collaborative for Health | — |
| Unknown | Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis NCT03386890 | Beijing Friendship Hospital | — |
| Recruiting | Biomarkers in the Diagnosis and Prognosis of NAFLD NCT06098417 | University of Trieste | — |
| Completed | Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. NCT06267794 | Jorge L Poo | Phase 2 |
| Completed | Shear Wave Sonoelastography in Pediatric Liver Fibrosis NCT02372682 | St. Louis University | — |
| Completed | Development of a Novel Biomarker for Liver Fibrosis NCT02348814 | University of California, Los Angeles | — |
| Completed | ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B NCT02313649 | SuperSonic Imagine | — |
| Completed | Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae NCT02165488 | The University of Hong Kong | — |
| Completed | A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV NCT02138253 | Conatus Pharmaceuticals Inc. | Phase 2 |
| Completed | FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis NCT02476695 | Wuxi Hisky Medical Technology Co Ltd | — |
| Completed | Liver Fibrosis Assessment With ShearWave Elastography NCT02181452 | SuperSonic Imagine | — |
| Completed | Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT NCT01825213 | Massachusetts General Hospital | — |
| Completed | Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liv NCT02041780 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepat NCT01934777 | Bambino Gesù Hospital and Research Institute | Phase 3 |
| Completed | Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases NCT01988753 | Baylor College of Medicine | — |
| Completed | Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa NCT02060162 | University of Alabama at Birmingham | — |
| Completed | Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) NCT01810458 | University of Florida | — |
| Unknown | A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing H NCT01965418 | Beijing 302 Hospital | Phase 4 |
| Completed | Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters NCT01962155 | Peking University First Hospital | — |
| Unknown | Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With C NCT01981421 | Yonsei University | — |
| Completed | Optimized Treatment and Regression of HBV-induced Liver Fibrosis NCT01938781 | Beijing Friendship Hospital | Phase 4 |
| Completed | Influence of Probiotics Administration Before Liver Resection in Liver Disease NCT02021253 | University Hospital, Rouen | N/A |
| Completed | Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease. NCT01789008 | Rennes University Hospital | N/A |
| Unknown | An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasi NCT02174367 | King's College London | — |
| Completed | Ultrasound Based Acoustic Radiation Force Impulse Imaging NCT01781208 | University of Michigan | N/A |
| Completed | Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis NCT01707472 | Gilead Sciences | Phase 2 |
| Recruiting | Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues NCT01757730 | Arunark Kolipaka | — |
| Completed | Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With C NCT01537965 | University Hospital, Grenoble | N/A |
| Completed | Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects NCT02603666 | Karolinska University Hospital | N/A |
| Completed | Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection NCT01231685 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 |
| Completed | Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis NCT01452308 | Gilead Sciences | Phase 2 |
| Terminated | Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection NCT01341106 | RWTH Aachen University | Phase 4 |
| Unknown | Visceral Stiffness Measurement Using Acoustic Radiation Force Impulse NCT01311934 | China Medical University Hospital | — |
| Completed | Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome NCT02353767 | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | — |
| Unknown | Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver Fibrosis NCT01268865 | China Medical University Hospital | — |
| Unknown | Improved Prevention of Perinatal Hepatitis B Transmission NCT01133184 | Hadassah Medical Organization | Phase 4 |
| Completed | Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone NCT01454336 | Royan Institute | Phase 1 |
| Completed | Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated NCT01935817 | University of Catania | Phase 3 |
| Completed | Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity NCT01082419 | University Hospital, Bordeaux | N/A |
| Completed | Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis NCT01072721 | Assistance Publique - Hôpitaux de Paris | N/A |
| Unknown | Antioxidant Supplements in the Reversal of Schistosomal Peri-portal Fibrosis NCT01260012 | Addis Ababa University | N/A |
| Completed | Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy NCT06868394 | Suez Canal University | — |
| Completed | Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED) NCT00896233 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients NCT00926224 | Echosens | N/A |
| Completed | Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis NCT01572064 | University of Nottingham | N/A |
| Completed | A Potential Novel Marker for Liver Fibrosis in NASH: the Soluble Secreted Form of the Human Asialoglycoprotein NCT00941902 | Ziv Hospital | — |
| Completed | Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) NCT00885313 | Bambino Gesù Hospital and Research Institute | Phase 1 / Phase 2 |
| Completed | Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Lef NCT00777725 | Monash University | — |
| Terminated | Screening of Fibrosing and/or Viral Chronic Hepatopathies in Jail NCT00453869 | University Hospital, Angers | — |
| Completed | Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy NCT00326482 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha NCT00323804 | ANRS, Emerging Infectious Diseases | Phase 2 / Phase 3 |
| Completed | Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis NCT00956098 | HK inno.N Corporation | Phase 2 |
| Completed | Prospective Evaluation of FibroScan in Patients Treated With Methotrexate NCT00673101 | Association HGE CHU Bordeaux Sud | — |
| Completed | Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection NCT00180674 | Imperial College London | Phase 2 |
| Completed | Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver NCT01241227 | Association HGE CHU Bordeaux Sud | — |
| Terminated | Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Ca NCT00151671 | Rennes University Hospital | Phase 2 / Phase 3 |
| Completed | Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C NCT00298714 | Hospital Clinic of Barcelona | Phase 4 |
| Completed | Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED NCT00049842 | Merck Sharp & Dohme LLC | Phase 3 |
| Terminated | Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C NCT00119119 | French National Agency for Research on AIDS and Viral Hepatitis | Phase 3 |
| Completed | Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis NCT00043303 | InterMune | Phase 2 |